Balanced ETF portfolios USD Q1 2021 commentary

SaxoSelect Commentaries

Saxo Bank

Asset classesStocks (developed and emerging equity), bonds, non-traditional
InstrumentsETFs
Investment styleMacro, diversified investment focus
Quarterly return (net of fees) 
Defensive-1.19%
Moderate2.43%
Aggressive 
3.74%

Market overview

The year of 2020 ended on a strong footing with equity markets recording solid gains. Much of that was a result of improving sentiment based on news about effective vaccines, a followed inoculation drive that started in early 2021, and well-coordinated recovery measures by governments across the globe. The remainder of the first quarter did not disappoint. 

After the Democrat victory in Georgia, the US launched yet another impressive stimulus package. Combined with a strong vaccine rollout in the US and UK, investors are hoping for a sustainable reopening of the economy. As a result, sentiment remained positive - equity markets and commodities reflected that by good performance while treasury yields rose in sync.

On the equity side, developed markets reported the highest returns led by Japan, Europe and the US. This was partly driven by the vaccine rollout but also a generally higher demand in goods as reflected by expanding manufacturing. Financials have benefitted the most given higher yield and steeper curves while growth stocks have suffered as a result. Value and size factor have largely benefitted from these dynamics. Emerging markets and Asia posted lower but positive returns in Q1, taking a breather after a stellar year and the strongest quarterly returns over a decade in Q4 2020. This was predominantly driven by the selloff in Chinese equities in February while the recent strengthening of the US Dollar also played its role.

Looking at fixed income, there are concerns that the mentioned positive drivers, in combination, could lead to an increase in inflation and thereby a tighter monetary policy in the near future. However, the Federal Reserve in the US has voiced out that it does not expect to raise rates before 2024. Yet, that fear is reflected in bond yields where government bonds and investment grade credit suffered the most and posted negative returns. The riskier high yield names, as a result of its correlation to equity, managed to close the quarter with low single digit returns. 

 

Portfolio performance

Returns net of feesDefensiveModerateAggressive
Jan-0.64%-0.29%-0.16%
Feb-1.21%0.76%1.21%
Mar0.67%1.96%2.65%
20207.2%10.0%9.8%
Since Inception (Feb 2017)18.6%32.5%4.1%

The moderate and aggressive portfolios produced positive returns in Q1, while the defensive portfolio posted a negative performance. Broadly speaking, our overweight to equities has paid off as the asset class performed strongly. In absolute terms, all equity positions contributed positively led by US equity and followed by emerging markets and Europe. From a relative standpoint, since the February rebalance, our overweight to Europe and the US has contributed positively while the overweight in EM and underweight to the UK has detracted.

The fixed income allocations reflect the general market  observations. In absolute terms, contributions were mainly negative with the exception of high yield and interest hedged credit. Long-dated US treasuries were the largest detracting force although our underweight to duration has helped shielding some of that off. 

Portfolio Allocation and top portfolio holdings (as of 16 Apr 2021)

Q121-balanced-defensive-USD

Q121-balanced-moderate-USD

Q121-balanced-aggressive-USD

 

Outlook

The investment management team (the “investment team” or the “team”) remains optimistic on equity and maintain the equity overweight in the Multi-Asset portfolios. 

Within the Equity sleeve, the team underweights EMU because of deteriorated valuations and rather weak earnings momentum. The vaccination rate in EMU is lower than the UK and US which is likely to delay the recovery in the region compared to other markets. On the other hand, the team trimmed the underweight to UK to neutral given the higher inoculation rate. The investment team also added allocation to Japan as valuations improved. Exposures such as UK and Canada have a generally higher allocation to Financials and Energy and therefore benefit from increasing inflation expectation. 

The team maintained the overweight to the US as valuation and earnings momentum continued to improve. Allocations to emerging markets are also maintained as it provides a diversification benefit to the overall portfolio. 

Within the fixed income sleeve, the team maintains the current duration at portfolio level, which is about 0.3 to 0.5 years less compared to the index benchmark across different risk profiles. The team is adding to high yield as spread momentum continued to be positive, mainly funded from credit. The team trimmed the underweight to mortgages to achieve a better balance of portfolio risk. 

The investment team keeps the allocation within the alternative sleeve for all three risk profiles for diversification purposes.

Disclaimer

Any information found in this document, including performance information and statistics are subject to change. You can find the latest updated pricing information on the description page for each available portfolio. In providing this material Saxo Bank has not taken into account any particular recipient’s investment objectives, special investment goals, financial situation, and specific needs and demands and nothing herein is intended as a recommendation for any recipient to invest or divest in a particular manner and Saxo Bank assumes no liability for any recipient sustaining a loss from trading in accordance with a perceived recommendation. All investments entail a risk and may result in both profits and losses, and all capital is at risk. In particular investments in leveraged products, such as but not limited to foreign exchange, derivatives and commodities can be very speculative and profits and losses may fluctuate both violently and rapidly. Speculative trading is not suitable for all investors and all recipients should carefully consider their financial situation and consult financial advisors in order to understand the risks involved and ensure the suitability of their situation prior to making any investment, divestment or entering into any transaction. Any mentioning herein, if any, of any risk may not be, and should not be considered to be, neither a comprehensive disclosure of risks nor a comprehensive description of such risks. Any expression of opinion may not reflect the opinion of Saxo Bank and all expressions of opinion are subject to change without notice (neither prior nor subsequent).

SaxoSelect Balanced Portfolios are offered by Saxo Bank. BlackRock’s data which is utilised by Saxo Bank in building the SaxoSelect Balanced Portfolios is based upon certain internal assumptions and BlackRock has not considered the suitability of the content of its data against individual needs and risk tolerances for all investors. As such, BlackRock’s data is for information purposes only and does not constitute investment advice or an offer to sell or a solicitation of an offer to buy the securities described within. BlackRock’s data has not been prepared in accordance with the legal requirement designed to promote the independence of investment data and is not subject to any prohibition on dealing ahead of the dissemination of the data provided to Saxo Bank and, as such, is considered to be a marketing communication to Saxo Bank. 

iShares and BlackRock are registered trademarks of BlackRock, Inc. and its affiliates (“BlackRock”) and are used under license. BlackRock is not affiliated with Saxo Bank. BlackRock makes no representations or warranties regarding the advisability of investing in any product, portfolio or service offered by Saxo Bank or any of its affiliates. BlackRock has no obligation or liability in connection with the operation, marketing, trading or sale of any product, portfolio or service offered by Saxo Bank or any of its affiliates nor does BlackRock have any obligation or liability to any client or customer of Saxo Bank.


Due to coronavirus controls, we are not able to meet with clients in our reception at present, unless by appointment in exceptional circumstances. We remain at your service on the phone and email details below. Thank you for your understanding.

Please expect very long waiting times on the line when calling us, we advise you to send us an email instead.

Contact Saxo

Select region

UAE
UAE

Trade responsibly
All trading carries risk. Read more. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more

Saxo Bank A/S is licensed by the Danish Financial Supervisory Authority and operates in the UAE under a representative office license issued by the Central bank of the UAE.

The content and material made available on this website and the linked sites are provided by Saxo Bank A/S. It is the sole responsibility of the recipient to ascertain the terms of and comply with any local laws or regulation to which they are subject.

The UAE Representative Office of Saxo Bank A/S markets the Saxo Bank A/S trading platform and the products offered by Saxo Bank A/S.